Search
for
Sort by
Research 241–270 of 878
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Cancer-Related Alopecia Risk and Treatment
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Drug Repurposing in Dermatology: Molecular Biology and Omics Approach
- The physiological and pharmacological roles of prostaglandins in hair growth
- Janus kinase inhibitors for alopecia areata: A narrative review
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Overview of Alopecia Areata
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Alopecia Areata: An Evidence-Based Treatment Update
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Frontal Fibrosing Alopecia: A Review
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Alopecia areata: medical treatments
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- New Modalities in the Treatment of Refractory Alopecia Areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Medical Treatment of Alopecia
- Oral Presentations
- Alopecia areata – Current understanding and management
- Chemotherapy‐induced alopecia – the urgent need for treatment options
- Recurring Chemotherapy-Associated Alopecia Areata: Case Report and Literature Review